Started: 2/2020
Study name: A phase 3, randomized, double-blind trial to evaluate the safety and immunogenicity of a 20-valent pneumococcal conjugate vaccine in healthy infants
Indication: Pneumococcal
Principal Investigators: Brad Brabec, Dave Meduna